Many studies suggest that mitochondrial ATP-sensitive potassium (K ATP ) channels play a key protective role in normothermic ischemia-reperfusion injury (5, 6, 14, 18, 30) .
Moderate hypothermia protects against cardiac ischemia by prolonging the time to stunning or permanent damage (4, 26, 29) . Hypothermia has the disadvantage of causing cytosolic [Ca 2ϩ ] overloading during storage, which leads to reduced diastolic ventricular compliance and contractility on rewarming and reperfusion (10, 24, 32) . It remains unclear whether brief ischemia also protects hearts against reperfusion injury after long-term moderately cold storage (4, 10, 28, 33, 34) . The effect of IPC after moderately cold storage on cytosolic [Ca 2ϩ ] loading has not been reported. Moreover, the role of sarcolemmal and mitochondrial K ATP channels in eliciting cardioprotection of IPC after cold storage is not known.
Moderate hypothermia (17°C) is widely used to protect hearts during open-heart surgery with circulatory arrest, and we have reported that two 2-min periods of global IPC before 30 min of ischemia at 37°C partially protected isolated guinea pig hearts against ischemiareperfusion injury (2, 18, 19) . Thus in the present study we used the same IPC protocol to test these hypotheses: 1) brief ischemia before 17°C storage for 4 h affords additive cardioprotection via a preconditioning mechanism; 2) protection elicited by IPC is related to decreased cytosolic [Ca 2ϩ ] loading during and after cold storage; and 3) protection by IPC results from sarcolemmal or mitochondrial K ATP channel opening.
METHODS
Isolated heart preparation and measurements. The investigation conformed to the Guide for the Care and Use of Laboratory Animals from the National Institutes of Health (NIH No. 85-23, Revised 1996) . Prior approval was obtained from the Medical College of Wisconsin Animal Studies Committee. Our preparation and measurements have been described in detail (1, 2, 18, 24, 26, 35, 36) . Forty guinea pig hearts of either sex were prepared by the Langendorff method and perfused at 55 mmHg with Krebs-Ringer solution. The perfusate had the following control composition (in mmol/l): 137 Na ϩ , 4. (LVP) and LV first derivative of pressure (LV dP/dt) were measured with diastolic LVP set to 0 mmHg initially. Coronary inflow was measured ultrasonometrically, and coronary effluent Na ϩ , K ϩ , Ca 2ϩ , PO2, PCO2, and pH were measured off-line. Coronary outflow (coronary sinus) O 2 tension was also measured continuously on-line with an O2 clark-type electrode. Myocardial O 2 consumption (MV O2) was calculated as (coronary flow/g) ϫ (arterial PO2 Ϫ venous PO2) ϫ 24 l O2 /ml at 760 mmHg; and cardiac work efficiency was calculated as LVDP ϫ HR/MV O2, where HR is heart rate.
Measurement of cytosolic and noncytosolic free Ca 2ϩ in intact hearts. We have published these methods and calibrations in detail (1, 2, 24, 26, 35, 36) . In brief, intracellular Ca 2ϩ was measured by spectrofluorometry at the LV free wall using a trifurcated fiber optic cable to direct the excitation and emission wavelengths. Hearts were loaded with the Ca 2ϩ -sensitive dye indo 1-AM. Indo-1 fluorescence (F) intensity was corrected for background F and the changes in F due to hypothermia, ischemia, and reperfusion in six additional hearts, wherein the same cooling, storage, and warming protocols were used as for Ca 2ϩ determination except that only the vehicle was perfused. Calibration curves were derived using modifications of the standard equation for fluorescent indicators used by Brandes et al. (3) . In brief, total intracellular ([Ca 2ϩ ]tot) was calculated from the total F385 to total F 456 ratio (Rtot), minimum ratio (Rmin), and maximum ratio (R max), and dissociation constant (Kd) according to the equation: [Ca 2ϩ ]tot ϭ S456 ϫ Kd [(Rtot Ϫ Rmin)/(Rmax Ϫ Rtot)], where S is a calibration constant.
Noncytosolic F (mostly mitochondrial) was measured at the end of each experiment (425 min) after perfusing hearts with 100 mol/l MnCl2 for 10 min to quench F derived from the cytosolic compartment; this does not alter the LVP transients. Details of this subtraction method have been published previously (24, 26, 35 ] for each group was 228 Ϯ 6 nM for control (CON), 226 Ϯ 4 nM for IPC, 242 Ϯ 5 nM for IPC ϩ 5-hydroxydecanoate (5-HD), and 226 Ϯ 5 nM for IPC ϩ glibenclamide (GLB); baseline total cell diastolic [Ca 2ϩ ] values were 160 Ϯ 4 nM for CON, 152 Ϯ 3 nM for IPC, 166 Ϯ 3 nM for IPC ϩ 5-HD, and 152 Ϯ 4 nM for IPC ϩ GLB. These values were not different among groups. The K d is inversely proportional to temperature. Free indo-1 reduces the fluorescence ratio F385/F456 in a nearly linear fashion by 0.30, 0.23, and 0.16 per 10°C fall, so that Kd increased 28% at 27°C (305 nmol/l), 44% at 17°C (354 nmol/l), and 67% at 7°C (385 nmol/l) (24, 26) . The linear relationship ( y ϭ mx ϩ b) for temperature and Kd was Kd ϭ Ϫ4.6°C ϩ 423.8 (r 2 ϭ 0.99). Loss of membrane integrity in infarcted cells on reperfusion could result in the leakage of indo-1 and lower signal intensities; however, because this is a ratiometric determination of [Ca 2ϩ ], both F signals degrade similarly so that the F ratio is relatively unchanged and remains no less than half the postloaded signal strength and fivefold greater than the unloaded signal strength (24, 26, 35) .
Cumulative effluent creatine kinase (CK) concentration, a marker of cell demise and membrane integrity, was measured (Creatine Kinase Flex reagent cartridge, Dade Behring Dimension; Newark, DE; sensitivity Ͼ10 U/l) by collecting the effluent continuously on reperfusion and spot sampling the collected effluent at 5 and 15 min. CK release was expressed as (U/1,000 ml) ⅐ ml collected per minute wet heart weight (U ⅐ g Ϫ1 ⅐ min Ϫ1 ). The 2,3,5-triphenyltetrazolium chloride staining technique was used to determine infarct size. The infarcted and noninfarcted tissues of left and right ventricles were carefully dissected and weighed so that percent infarct size was expressed as a percentage of total heart weight (1, 5) .
Protocol. Hearts were randomly divided into four groups of 10 hearts each: nontreated hypothermic ischemia controls (CON), IPC, IPC ϩ GLB, and IPC ϩ 5-HD. Initial background (before indo-1 loading) measurements were obtained after 30 min of stabilization. Each heart was then loaded with indo-1 dye for 30 min followed by a 20-min washout of residual dye. Ca 2ϩ transient recordings were obtained every 1 to 5 min during normothermia, cooling, and rewarming, and once per hour during hypothermic storage. Systolic LVP (mmHg) before indo-1 loading was not different among groups: CON, 90 Ϯ 3; IPC, 90 Ϯ 5; IPC ϩ 5-HD, 92 Ϯ 4; and IPC ϩ GLB, 91 Ϯ 4. Thus systolic LVP decreased by 25-30% after indo-1 loading and washout (Table 1 , baseline), but there were no differences among groups. Perfusate and bath were maintained at 37°C before and after hypothermic ischemia in each group by a heated water circulator and at 17°C during ischemia by a parallel, refrigerated water circulator. All hearts in each group were subjected to 4 h of global ischemia at 17°C, and it took 15 min (100-115 min) for hearts to cool down from 37°C to 17°C before ischemia, and 10 min (355-365 min) to warm up from 17°C to 37°C after ischemia. The IPC protocol was two 2-min periods of global ischemia separated by 5 or 6 min of reperfusion at 37°C, and IPC was initiated beginning at 85 min and ending before the onset of cooling (Fig. 1, A and B, and Fig. 2A ). 5-HD (200 mol/l) and GLB (10 mol/l) were perfused from 5 min before IPC until the onset of global hypothermic ischemia (80-115 min, Fig. 2A ). In preliminary experiments (n ϭ 4), GLB or 5-HD given before hypothermic storage did not alter any measured functional, metabolic, or structural variable compared with the CON hypothermia group (data not shown). Bradykinin (BK, 10 nmol/l) and sodium nitroprusside (SNP, 100 mol/l) were perfused for 3 min after 30-45 min of reperfusion to assess maximally stimulated endothelial [Ca 2ϩ ] and endothelial and nonendothelial-dependent vasodilation. BK increased diastolic [Ca 2ϩ ] by about 16% for all groups; nitroprusside had no effect on diastolic [Ca 2ϩ ] (see Fig. 1 ). MnCl2 was perfused for quenching noncytosolic [Ca 2ϩ ] (see METHODS). LVP and LV dP/dt, coronary flow, and coronary sinus PO2 were measured continuously before and after hypothermic ischemia. Cytosolic [Ca 2ϩ ] and LVP were recorded continuously at all temperatures to 17°C and back to 37°C.
All data were expressed as means Ϯ SE. One-way analysis of variance for repeated measures (Super Anova 1.11 software for Macintosh from Abacus Concepts; Berkeley, CA) was used to assess within-group differences over time. Among groups data were compared at discrete time points before cooling at 37°C (baseline, at 80 min), after 4 h of hypothermic ischemia (at 355 min), and during rewarming and reperfusion (at 357, 365, 385, and 415 min). Two-way analysis of variance was used to assess among-group differences at these time points. If F values for the analysis of variance were significant, Tukey's multiple-comparison post hoc tests were used to differentiate within or among group differences. Differences among means were considered significant when P Ͻ 0.05. Figure 1 , A and B, and Fig. 2A display changes in diastolic [Ca 2ϩ ], developed LVP, and diastolic pressure before, during, and after cold ischemia and reperfusion in CON and IPC groups. Diastolic [Ca 2ϩ ] increased incrementally during hypothermic ischemia, rose abruptly and markedly during initial rewarming and reperfusion, and remained elevated throughout reperfusion in the CON group. The two 2-min periods of IPC before the index cold ischemia significantly decreased the diastolic [Ca 2ϩ ] overloading both during hypothermic ischemia and during rewarming and reperfusion. BK increased diastolic [Ca 2ϩ ]; SNP had no effect. MnCl 2 decreased total [Ca 2ϩ ] (see METHODS). After 10 min of reperfusion, diastolic [Ca 2ϩ ] returned to baseline in the IPC, but not in CON, IPC ϩ 5-HD, and IPC ϩ GLB groups ( Fig. 1A and Table 1 ). Developed LVP (systolic Ϫ diastolic LVP) was lower than the baseline value in each group during cold ischemia and reperfusion, but it was higher in the IPC group than in CON, IPC ϩ 5-HD, and IPC ϩ GLB groups at 10 min of reperfusion and remained higher in the IPC group than in the CON group at 60 min of reperfusion ( Fig.  1B and Table 1 ). Diastolic LVP increased similarly in each group on initial reperfusion compared with the baseline values. Diastolic LVP remained markedly elevated in the CON group throughout reperfusion, whereas it gradually returned to nearly the baseline value in the treated groups after 10 min of reperfusion without significant differences among groups ( Fig. 2A) . Table 1 summarizes changes in indexes of cytosolic [Ca 2ϩ ], HR, and LVP in CON, IPC, IPC ϩ 5-HD, and IPC ϩ GLB groups before and at the end of cold ischemia, and at 2, 10, and 60 min of reperfusion. Systolic LVP was depressed during early rewarming and reperfusion and increased during later reperfusion with no significant differences among the groups. Systolic [Ca 2ϩ ], which is the same as diastolic [Ca 2ϩ ] during cold ischemia, was increased markedly by the end of ischemia compared with preischemic diastolic Heart rate, beats/min
RESULTS
Developed LVP, mmHg [Ca 2ϩ ] values, and rose abruptly and markedly on initial reperfusion at 2 min (24°C); at this time, the rise in systolic [Ca 2ϩ ] was less in IPC and IPC ϩ GLB groups than in CON and IPC ϩ 5-HD groups. After 10 and 60 min of reperfusion, systolic [Ca 2ϩ ] had returned to baseline values in each group. HR was zero during cold ischemia and lower than baseline values in each group at 2 and 10 min of reperfusion, whereas it returned to baseline value beginning after 10 min of reperfusion without significant differences among groups. Rate-pressure product (RPP, HR ϫ developed LVP) was zero during cold ischemia and much lower than the baseline value in each group at 2 min of reperfusion, whereas it was higher in the IPC group than in CON, IPC ϩ 5-HD, and IPC ϩ GLB groups at 10 min of reperfusion. RPP remained lower than baseline values in each group at 60 min of reperfusion, but there were no significant differences among groups. Table 2 displays changes in maximal (LV dP/dt max ), minimal (LV dP/dt min ), MV O 2 , cardiac efficiency, and coronary flow in CON, IPC, IPC ϩ 5-HD, or IPC ϩ GLB groups before and during hypothermic ischemia and reperfusion. LV dP/dt max and LV dP/dt min was nil during ischemia and returned to 38% and 28% of its preischemic value by 10 min of reperfusion in the IPC group; LV dP/dt max was higher in the IPC than in the CON (25%) group but not different from the IPC ϩ 5-HD (34%) or IPC ϩ GLB (30%) groups. LV dP/dt min was higher in the IPC group by 10 min of reperfusion than that in the CON (16%), IPC ϩ 5-HD (19%) or IPC ϩ GLB (18%) groups. There were no differences in Fig. 2 . Time course of diastolic LVP (A) before, during, and after 4 h of cold global ISC at 17°C. Diastolic LVP decreased during cold ISC and increased during initial reperfusion in each group compared with baseline value at perfusion 80 min. Diastolic LVP was markedly elevated throughout reperfusion in the CON group, whereas it gradually returned to the baseline value after reperfusion 10 min in the IPC, IPC ϩ 5-hydroxtdecanoate (5-HD), and IPC ϩ glibenclamide (GLB) groups. B: effluent creatine kinase (CK) release at reperfusion 15 min and infarct size determined by percent whole heart weight at 70 min of reperfusion. Treatment with IPC significantly decreased infarct size and CK release compared with CON, IPC ϩ 5-HD, and IPC ϩ GLB groups. There were no differences in CK release and infarct size among CON, IPC ϩ 5-HD, and IPC ϩ GLB groups. LV dP/dt max among groups, but LV dP/dt min was still higher in the IPC group than in the CON group at 60 min of reperfusion. MV O 2 was higher after IPC than CON at 2, 10, and 60 min of reperfusion. Cardiac efficiency was nil at 2 min of reperfusion and remained depressed at 10 min of reperfusion, but it was higher in the IPC group than in other groups. At 60 min of reperfusion cardiac efficiency was restored similarly in all groups. Coronary flow was higher in the IPC group than in CON group at 30 and 60 min of reperfusion. On reperfusion at 30 min, coronary flow responses to BK and SNP were increased significantly in each group, but were increased more after IPC compared with the CON group.
Heart weight was not different among groups: CON, 1.51 Ϯ 0.01 g; IPC, 1.51 Ϯ 0.02 g; IPC ϩ 5-HD, 1.50 Ϯ 0.01 g; and IPC ϩ GLB, 1.52 Ϯ 0.06 g. Infarct size was much smaller in the IPC group than in the CON, IPC ϩ 5-HD, and IPC ϩ GLB groups, whereas there were no differences in infarct size among CON, IPC ϩ 5HD, and IPC ϩ GLB groups (Fig. 2B) . At 5 min of reperfusion, effluent CK release (U ⅐ g Ϫ1 ⅐ min Ϫ1 ) was not different among groups: CON, 2.28 Ϯ 0.31; IPC, 2.67 Ϯ 0.53; IPC ϩ 5-HD, 1.79 Ϯ 0.67; and IPC ϩ GLB, 2.16 Ϯ 0.24. At 15 min of reperfusion, it was much lower in the IPC group than in CON, IPC ϩ 5-HD, and IPC ϩ GLB groups (Fig. 2B) .
DISCUSSION
This study demonstrates for the first time in intact hearts that two brief periods of global IPC applied before sustained 4 h of cold global ischemia at 17°C improved mechanical and metabolic function, coronary flow, and cardiac efficiency. In addition, IPC significantly reduced cytosolic [Ca 2ϩ ] loading on reperfusion, decreased infarct size, and reduced CK release. Furthermore, the reduction of infarct size by IPC was blocked by 5-HD and by GLB; functional and metabolic improvements by IPC were attenuated, but not completely inhibited by 5-HD and by GLB. This work demonstrates that IPC adds to the cardioprotection of moderate hypothermia during prolonged ischemia and that IPC-induced protection is associated with decreased [Ca 2ϩ ] loading and caused, in part, by K ATP channel opening. Ϫ621 Ϯ 62 IPC and hypothermic ischemia-reperfusion injury. We have shown in the same model that IPC was demonstrated by significantly increased contractility and improved relaxation after 30 min of 37°C global ischemia, that this was associated with improved association of cytosolic [Ca 2ϩ ] and function, and that K ATP channel blockade reversed the protective effects of IPC (2, 18). Ogino et al. (20) showed that IPC (5 min of global ischemia and 10 min of reperfusion at 37°C) before 6 h of cold global ischemia at 6°C primarily improved diastolic relaxation. We observed similarly that IPC before hypothermic ischemia improved cardiac diastolic relaxation with little effect on systolic function. These studies show the powerful cardioprotective effect of hypothermia alone. The extent of added protection by IPC before hypothermic ischemia, however, is relatively small compared with that observed in normothermic hearts with shorter-term ischemia. The beneficial effect of IPC plus hypothermia was manifested by improved diastolic relaxation.
Several different temperatures, animal species, ischemia periods, and IPC protocols have been used to examine additive cardioprotective effects of IPC and hypothermia (4, 10, 28, 33, 34) . In severe hypothermia studies, it was reported that IPC (5 min of global ischemia plus 5 min of reperfusion at 37°C) before 115, 135, and 160 min of global ischemia at 20°C added to the hypothermia-induced functional protection in isolated rat hearts (4). In contrast, IPC (two cycles, 3 min of global ischemia plus 5 min of reperfusion at 37°C) improved postischemic cardiac function in isolated rat hearts after 25 min of global ischemia at 37°C, but not in hearts at 3.5, 4, and 5 h of cold ischemia at 6°C (33) . In studies on mild hypothermia, IPC (one cycle, 2 min of global ischemia plus 5 min of reperfusion at 37°C) improved cardiac function after 75 min of global ischemia at 23°C, but not after 5 h of cold ischemia at 6°C in isolated rat hearts (28) . IPC (two cycles, 5 min of global ischemia and 10 min of reperfusion at 34°C) improved postischemic cardiac function in isolated rat hearts after 60 min of global ischemia at 34°C but not after 60 min of ischemia at 10°C (9) . IPC in vivo rats also showed additive cardioprotection with mild hypothermia (8, 34) .
Taken together, these studies indicate that IPC adds to the protection of hypothermia but that differences in IPC protocol, duration of ischemia, and temperature lead to variable results. Because hypothermia itself is so cardioprotective, IPC can be shown to occur only after long-term ischemia when the protective effects of hypothermia alone wane. In this study, we selected 4-h, 17°C ischemia because the functional return of control hearts was Ͻ50% of the baseline values, indicating that the cardioprotection of hypothermia diminishes over time. Because high K ϩ solutions add to the protection of hypothermia (26), we perfused hearts only with normal ionic Krebs-Ringer solution. We reported that two 2-min periods of global ischemia before 30 min of ischemia provided significant cardioprotection in isolated guinea pig hearts (2, 18 ] during ischemia and reperfusion at 37°C in intact guinea pig hearts (2, 35) . We found that high systolic [Ca 2ϩ ] was associated with reduced contractile force and impaired relaxation on reperfusion and that IPC (two 2-min periods of ischemia) simultaneously reduced systolic and diastolic [Ca 2ϩ ] overloading and improved systolic and diastolic function. In the present study we observed that the higher cytosolic [Ca 2ϩ ] after hypothermic ischemia was also associated with depressed cardiac function. In contrast to normothermic ischemia, systolic [Ca 2ϩ ] loading occurred only during the initial reperfusion and then returned to preischemic values during later reperfusion. However, diastolic [Ca 2ϩ ] was markedly increased and remained elevated throughout the reperfusion. IPC before hypothermic ischemia significantly reduced diastolic [Ca 2ϩ ] loading and improved diastolic function. We have also reported that cardioplegia decreases diastolic [Ca 2ϩ ] loading and improves relaxation after 4 h of hypothermic storage at 3°C in isolated guinea pig hearts (26) and that hearts perfused at 17°C (no ischemia) had markedly elevated diastolic [Ca 2ϩ ] and impaired relaxation function (24) . Taking these results together, we conclude that diastolic [Ca 2ϩ ] overloading plays a key role in the development of impaired myocardial relaxation during hypothermic ischemia and normothermic reperfusion and that IPC improves cardiac relaxation by reducing diastolic [Ca 2ϩ ] loading. IPC, hypothermic ischemia reperfusion injury, and K ATP channel opening. IPC confers protection to the myocardium through a signal-transduction pathway that encompasses both a "trigger" phase, which occurs before sustained ischemia, and a "mediator" phase, which occurs during prolonged ischemia (6, 21) . For example, it was reported that the mitochondrial K ATP channel inhibitor 5-HD, bracketing either 5 min of IPC ischemia or 5 min of 10 M diazoxide (a mitochondrial K ATP channel opener) perfusion, blocked the anti-infarction effect of IPC or diazoxide infusion in isolated rabbit hearts. However, 5-HD starting just 5 min before index ischemia did not affect the cardioprotection of IPC. Thus it was suggested that mitochondrial K ATP channels mainly serve as the trigger effect (21) . However, it was also found that 5-HD attenuated cardioprotection in in vivo rats when administered either 5 min before the IPC stimulus, during the reperfusion phase of the IPC stimulus, or 5 min before reperfusion during prolonged ischemia; it was concluded that activation of mitochondrial K ATP channels is an important downstream regulator of myocardial protection with effects lasting into the reperfusion period following prolonged ischemia (6) . Another study suggested that mitochondrial K ATP channel opening both triggered and mediated cardioprotection in isolated rabbit hearts (38) . Thus it has been suggested that opening K ATP channels in the mitochondrial inner membrane is an essential step leading to protection against infarction by ischemic preconditioning during normothermic ischemia (13) .
In our study of long-term cold ischemia in intact guinea pig hearts, the IPC-induced effect to reduce infarct size was blocked when bracketed by either mitochondrial K ATP channel inhibition or combined sarcolemmal K ATP and mitochondrial K ATP inhibition. Because mitochondrial K ATP channels may open during a trigger phase and during a mediator phase (38), we perfused 5-HD or GLB from 5 min before IPC until the onset of global ischemia to block any K ATP channel opening during both brief ischemia (IPC) and the longterm (index) cold ischemia. However, although lower concentrations of 5-HD are claimed to be specific for mitochondrial K ATP channels in rat (5) and rabbit (21) hearts in vitro at 200 M, in guinea pig hearts, 5-HD may have an additional effect on the sarcolemmal K ATP channel (16, 17) . Thus our results suggest that, like IPC before normothermic ischemia, the protection against infarction by IPC before moderate hypothermic ischemia is modulated by mitochondrial K ATP and/or sarcolemmal K ATP channels.
Others have also reported that the IPC-induced smaller infarct size after short-term normothermic ischemia is not necessarily associated with better functional return (27, 31, 39) . IPC reduced infarct size in isolated mouse hearts after 20 min of global ischemia and reperfusion but did not improve cardiac functional return (39) . The adenosine-enhanced effect of IPC to reduce infarct size was blocked by either 5-HD or GLB, but the improvement in functional indexes was only blocked by HMR-1883 (a selective sarcolemmal K ATP channel inhibitor) and not by 5-HD or GLB (31) . Also, K ATP channels were reported to play an essential role in late IPC against infarction, but not in late IPC against stunning (27) . Our findings are consistent with these reports in that the improved functional effect induced by IPC before hypothermia was also partially blocked by 5-HD and GLB. Thus it appears that the improved cardiac function provided by IPC before hypothermia is mediated in part by opening sarcolemmal K ATP and/or mitochondrial K ATP channel after longterm cold ischemia and reperfusion.
IPC in rats (12) . It also was found that Na ϩ -K ϩ -ATPase activity of sarcolemmal vesicles was not depressed after 4 h of ischemia at 4°C or after 40 min of reperfusion at 37°C in rabbit hearts (7); however, sarcoplasmic reticulum Ca 2ϩ -ATPase activity was markedly lowered after hypothermic ischemia and reperfusion. It was suggested that [Ca 2ϩ ] loading during hypothermic ischemia and reperfusion resulted primarily from dysfunctional Ca 2ϩ handling ability in the sarcoplasmic reticulum (7) . A Ca 2ϩ paradox may also lead to diastolic [Ca 2ϩ ] loading and diastolic dysfunction (11) . IPC before Ca 2ϩ paradox improved diastolic function and reduced diastolic [Ca 2ϩ ] loading via improved sarcoplasmic reticulum Ca 2ϩ -handling ability during the Ca 2ϩ paradox (11) . By inference, our results suggest that IPC decreases diastolic [Ca 2ϩ ] loading by improving sarcoplasmic reticulum Ca 2ϩ handling ability and or reducing Na ϩ /H ϩ exchange secondary to opening K ATP channel during hypothermic ischemia and reperfusion.
In summary, these results confirm that IPC before moderate hypothermic ischemia exerts additive cardioprotection with moderate hypothermia and that this is associated with decreased cytosolic [Ca 2ϩ ] overloading and is due, in part, to opening of K ATP channels. This protective effect of IPC may be clinically important because moderate hypothermia (17°C) is widely used to protect hearts during open-heart surgery (7).
